Last $6.22 USD
Change Today -0.03 / -0.48%
Volume 35.9K
ATNM On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - actinium pharmaceuticals inc (ATNM)

Name (Connections)Board RelationshipsTitleKey Developments
C. Nicholson B.S., Ph.D. 35 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee 
Richard Steinhart MBA 23 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee 

Compensation Committee* - actinium pharmaceuticals inc (ATNM)

Name (Connections)Board RelationshipsTitle
C. Nicholson B.S., Ph.D. 35 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
Sandesh Seth M.S.,MBA 26 RelationshipsChairman and Member of Compensation Committee
Richard Steinhart MBA 23 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee
ATNM Compensation vs. Industry
112.1K
365.2K
Chief Executive Officer
220.5K
270.4K
Chief Operating Officer
Share price activity for ACTINIUM PHARMACEUTICALS INC (ATNM)
52 Week Price Performance
ATNM
Industry Average

Advisory Committee* - actinium pharmaceuticals inc (ATNM)

Name (Board Relationships)/Title Board Affiliations
Elihu Estey 16 Relationships
Member of Clinical Advisory Board
No other board affiliations
Sergio Giralt 49 Relationships
Member of Scientific Advisory Board - Iomab(Tm)-B
No other board affiliations
Joseph Jurcic 16 Relationships
Chairman of Clinical Advisory Board
No other board affiliations
Hagop Kantarjian 35 Relationships
Member of Clinical Advisory Board
No other board affiliations
Judith Karp 24 Relationships
Member of Clinical Advisory Board
No other board affiliations
Hillard Lazarus 43 Relationships
Member of Scientific Advisory Board - Iomab(Tm)-B
No other board affiliations
M. Levy 16 Relationships
Member of Scientific Advisory Board for Iomab(TM)-B. Iomab(TM)-B
No other board affiliations
Peter McSweeney 16 Relationships
Member of Scientific Advisory Board - Iomab(Tm)-B
No other board affiliations
John Pagel 16 Relationships
Member of Clinical Advisory Board and Member of Scientific Advisory Board - Iomab(Tm)-B
No other board affiliations
Alexander Perl 16 Relationships
Member of Clinical Advisory Board
No other board affiliations
David Scheinberg 59 Relationships
Member of Clinical Advisory Board
No other board affiliations
Richard Wahl 16 Relationships
Member of Clinical Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATNM:US $6.22 USD -0.03

ATNM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ATNM.
View Industry Companies
 

Industry Analysis

ATNM

Industry Average

Valuation ATNM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 39.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTINIUM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.